XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Sep. 30, 2022
Summary of Financial Assets and Liabilities Measured at Estimated Fair Value on a Recurring Basis

The following table represents our financial assets and liabilities measured at estimated fair value on a recurring basis:

 

 

 

Fair value measurement using

 

 

 

 

 

 

Quoted

 

 

Significant

 

 

 

 

 

 

 

 

 

prices in

 

 

other

 

 

Significant

 

 

 

 

 

 

active

 

 

observable

 

 

unobservable

 

 

 

 

 

 

markets

 

 

inputs

 

 

inputs

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

September 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Short-term investments

 

$

396,702

 

 

$

-

 

 

$

-

 

 

$

396,702

 

Restricted short-term investments

 

 

12,352

 

 

 

-

 

 

 

-

 

 

 

12,352

 

Other financial assets

 

 

312

 

 

 

-

 

 

 

612,746

 

 

 

613,058

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Unsecured senior notes

 

 

-

 

 

 

321,128

 

 

 

-

 

 

 

321,128

 

Warrant derivative liability

 

 

-

 

 

 

-

 

 

 

691

 

 

 

691

 

Other liabilities

 

 

-

 

 

 

-

 

 

 

45,926

 

 

 

45,926

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Short-term investments

 

$

595,651

 

 

$

-

 

 

$

-

 

 

$

595,651

 

Restricted short-term investments

 

 

12,216

 

 

 

-

 

 

 

-

 

 

 

12,216

 

Other financial assets

 

 

490

 

 

 

-

 

 

 

787,816

 

 

 

788,306

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Unsecured senior notes

 

 

-

 

 

 

563,958

 

 

 

-

 

 

 

563,958

 

Liability arising from Acreage Arrangement

 

 

-

 

 

 

-

 

 

 

47,000

 

 

 

47,000

 

Warrant derivative liability

 

 

-

 

 

 

-

 

 

 

26,920

 

 

 

26,920

 

Other liabilities

 

 

-

 

 

 

-

 

 

 

70,066

 

 

 

70,066

 

Level 2  
Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 2 and Level 3 Financial Instruments

The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 2 financial instruments:

 

 

Financial asset / financial liability

 

Valuation techniques

 

Key inputs

 

Unsecured senior notes

 

Senior note pricing model

 

Quoted prices in over-the-counter broker market

Level 3  
Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 2 and Level 3 Financial Instruments

The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 3 financial instruments:

 

 

Financial asset / financial liability

 

Valuation techniques

 

Significant unobservable inputs

 

Relationship of unobservable inputs to fair value

 

Acreage financial instrument

 

Probability weighted expected return model

 

Probability of each scenario

 

Change in probability of occurrence in each scenario will result in a change in fair value

 

 

 

 

 

Number of common shares to be issued

 

Increase or decrease in value and number of common shares will result in a decrease or increase in fair value

 

 

 

 

 

Probability and timing of US legalization

 

Increase or decrease in probability of US legalization will result in an increase or decrease in fair value

 

 

 

 

 

Estimated premium on US legalization

 

Increase or decrease in estimated premium on US legalization will result in an increase or decrease in fair value

 

 

 

 

 

Control premium

 

Increase or decrease in estimated control premium will result in an increase or decrease in fair value

 

 

 

 

 

Market access premium

 

Increase or decrease in estimated market access premium will result in an increase or decrease in fair value

 

TerrAscend Exchangeable Shares, TerrAscend Option

 

Put option pricing model

 

Probability and timing of US legalization

 

Increase or decrease in probability of US legalization will result in an increase or decrease in fair value

 

Hempco Debenture

 

Discounted cash flow

 

Discount rate

 

Increase or decrease in discount rate will result in a decrease or increase in fair value

 

TerrAscend warrants - October 2019, March 2020

 

Black-Sholes option pricing model

 

Probability and timing of US legalization

 

Increase or decrease in probability of US legalization will result in an increase or decrease in fair value

 

TerrAscend warrants - December 2020

 

Monte Carlo simulation model

 

Probability and timing of US legalization

 

Increase or decrease in probability of US legalization will result in an increase or decrease in fair value

 

Arise Bioscience term loan, TerrAscend Canada term loan -

 

Discounted cash flow

 

Probability and timing of US legalization

 

Increase or decrease in probability of US legalization will result in an increase or decrease in fair value

 

October 2019, March 2020

 

 

 

Discount rate

 

Increase or decrease in discount rate will result in a decrease or increase in fair value

 

Wana financial instrument - Call

 

Discounted cash flow

 

Expected future Wana cash flows

 

Increase or decrease in expected future Wana cash flows will result in an increase or decrease in fair value

 

Option

 

 

 

Discount rate

 

Increase or decrease in discount rate will result in a decrease or increase in fair value

 

Wana financial instrument - Deferred Payments

 

Monte Carlo simulation model

 

Probability and timing of US legalization

 

Increase or decrease in probability of US legalization will result in an increase or decrease in fair value

 

 

 

 

 

Volatility of Wana equity

 

Increase or decrease in volatility will result in an increase or decrease in fair value

 

Jetty financial instrument -

 

Discounted cash flow

 

Expected future Jetty cash flows

 

Increase or decrease in expected future Jetty cash flows will result in an increase or decrease in fair value

 

Call Option

 

 

 

Discount rate

 

Increase or decrease in discount rate will result in a decrease or increase in fair value

 

Jetty financial instrument - Deferred

 

Monte Carlo simulation model

 

Probability and timing of US legalization

 

Increase or decrease in probability of US legalization will result in an increase or decrease in fair value

 

Payments

 

 

 

Volatility of Jetty equity and revenue

 

Increase or decrease in volatility will result in an increase or decrease in fair value

 

Warrant derivative liability

 

Monte Carlo simulation model

 

Volatility of Canopy Growth share price

 

Increase or decrease in volatility will result in an increase or decrease in fair value

 

BioSteel redeemable noncontrolling interest

 

Discounted cash flow

 

Discount rate

 

Increase or decrease in discount rate will result in a decrease or increase in fair value

 

 

 

 

 

Expected future BioSteel cash flows

 

Increase or decrease in expected future BioSteel cash flows will result in an increase or decrease in fair value

 

 

Vert Mirabel redeemable

 

Discounted cash flow

 

Discount rate

 

Increase or decrease in discount rate will result in a decrease or increase in fair value

 

noncontrolling interest

 

 

 

Future wholesale price and production levels

 

Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value